Rekombinanter INSM1 Antikörper (AA 81-125)
Kurzübersicht für Rekombinanter INSM1 Antikörper (AA 81-125) (ABIN7876886)
Target
Alle INSM1 Antikörper anzeigenAntikörpertyp
Reaktivität
Wirt
Klonalität
Konjugat
Applikation
Güteklasse
Klon
-
-
Bindungsspezifität
- AA 81-125
-
Verwendungszweck
- Recombinant INSM1 Antibody / Insulinoma-associated protein 1 (azide and preservative free)
-
Aufreinigung
- Protein A/G affinity
-
Immunogen
- A portion of amino acids 81-125 was used as the immunogen for the recombinant INSM1 antibody.
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
- Optimal dilution of the recombinant INSM1 antibody should be determined by the researcher.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- 1 mg/mL
-
Buffer
- 1 mg/mL in 1X PBS, BSA free, sodium azide free
-
Konservierungsmittel
- Azide free
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- Aliquot the recombinant INSM1 antibody and store frozen at -20oC or colder. Avoid repeated freeze-thaw cycles.
-
-
- INSM1 (Insulinoma-Associated 1 (INSM1))
-
Andere Bezeichnung
- INSM1
-
Hintergrund
- Insulinoma-associated protein 1 (INSM1) is a developmentally regulated zinc-finger transcription factor. It localizes to the nucleus and is expressed in embryonic issues undergoing neuroendocrine differentiation. INSM1 is not expressed in normal adult tissues but can be found highly expressed in neuroendocrine tumors. INSM1 is positive in 95 % of lung small cell carcinoma and 91 % of lung large cell neuroendocrine carcinoma, compared with 75 % and 78 % with the combined panel of traditional neuroendocrine markers (synaptophysin, chromogranin, and CD56).INSM1 stains 100 % of the atypical carcinoids, typical carcinoids and paragangliomas, but only 3 % of adenocarcinomas and 4 % of squamous cell carcinomas. Therefore, INSM1 is sensitive and specific to be a single first-line pan-neuroendocrine marker.
-
UniProt
- Q01101
Target
-